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Abstract 
The complete coding sequence of the human plasma membrane calcium ATPase (PMCA) isoform 3 was determined from overlapping 
genomic and cDNA clones. The cDNAs for the two major alternative splice variants 3a (3CII) and 3b (3CI) code for proteins of 1173 and 
1220 amino-acid residues, respectively, which show 98% identity with the corresponding rat isoforms. On a multiple human tissue 
Northern blot, a major PMCA3 transcript of about 7 kb was detected exclusively in the brain, demonstrating the highly restricted pattern 
of expression of this isoform to human neuronal tissues. With the elucidation of the human PMCA3 primary structure, complete sequence 
information is now available for the entire family of human PMCA isoforms. 
Keywords: ATPase, Ca2+-; Calcium pump; Isoform; Plasma membrane; (Human) 
Plasma membrane calcium pumps are responsible for 
ATP-driven, active Ca 2+ extrusion from eukaryotic ells. 
They belong to a growing family of cation pumps referred 
to as P-type ATPases based on their formation of a charac- 
teristic aspartyl-phosphate intermediate during the reaction 
cycle [1 ]. The mammalian plasma membrane calcium AT- 
Pases (PMCAs) are encoded by a multigene family com- 
prising four members in rats and humans. Additional iso- 
form diversity is generated from each primary gene tran- 
script by alternative mRNA splicing at two major 'hots- 
pots' called sites A and C [2,3]. Full-length coding se- 
quences have previously been determined for the rat PMCA 
isoforms 1, 2, 3, and 4 [4-6] and for the human PMCAs 1, 
2, and 4[7-9]. By contrast, only two small partial se- 
quences have so far been reported for the human PMCA3, 
covering the regions of alternative splicing at sites A and 
C [10]. Studies at both the mRNA and the protein level 
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have shown that PMCA3 expression is highly tissue- 
specific, essentially being restricted to brain and skeletal 
muscle [5,10-14]. The absence of PMCA3 mRNA in most 
tissues and its low abundance even in the brain have 
hampered previous attempts to obtain the full-length hu- 
man sequence for this isoform. Here, we report the com- 
plete coding sequence for the human PMCA3 as deter- 
mined by cDNA and genomic cloning as well as by PCR 
amplification of reverse transcribed mRNA. 
Isolation of  ouerlapping clones covering the entire cod- 
ing region of  the human PMCA3. A rat PMCA3 cDNA 
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Fig. 1. Scheme of the human PMCA3 cDNA and subclones used for 
sequencing. A composite of the final PMCA3 cDNA is shown on top; the 
length (in kb) is indicated. The coding sequence is represented by an open 
bar, 5' and 3' untranslated sequences are shown as black boxes. The 
positions of alternative splice sites A and C are also indicated. Sequences 
derived from genomic, DNA, and RT-PCR clones are indicated by grey, 
black, and stippled bars, respectively. 
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~TGTCC~CGCTT~C~-AGCTTTCTCACCGeCGCCAa~ACCTTGCCTGGGCACTGGGACCGTGGGTGGCCGCCTGTCCCT~GCTGTGGCTG~GCCAAG~TTGC~cTTGTG~GAAGGCCT~AC~GCAC~c~-TGGGC~AC~T~CC.~ATAGTTCA 150 
M G D M A N S S 8 
ATCGAGTTCCAC•CCAAG•cCCAGCAGCAGCGGGATGTCCCCCAGGcTGGAGGCTTTGGGTGCACGCTGG•GGAGCTGcGCACC•TCATGGAGCTG•GAGGGGCCGAGG•GCTGcAGAAGATCGAGGAGG•CTAcGGGGATGT•AG•GGG 500 
CTC TGC C G GAG GCTGAAGAC CT CACC CACAGAG~ C C TGG CGGACAAC ACCAATGACCTG GAG~AG C GCAGGCAGATC TACG GGCAGAAC'2T CATC CC C CC AAAGCAACCCAAGACCTT C C TG CAGC TGGT GTGGGAGGC C CTGCAGGAC 450 
GTGACcCTCATCATCcT~AGGTGGcT~CATCGTCTCTcTGGGcCTCTCGTTcTATCd2GccGCCAsGAGAGGAGAGTG"~CTGTGGG~A%TGTGTCGGGAGGCGCAGAAGATGAGGGCGAGGccGAAGcT~M~CTGGATCGAGGGGGcT 600 
h V T L I I L E V A A I V S L G L S F Y A P P G E E S E A C G N V S G G A E D E G E A E A G W I E G A 158 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
GCCATC•TGCTGTCCGTCATCTGTGTGGTGCTGGTcACGGCcTTCAATGA•TGGAGCAAGGAGAAGcAGTTCCGAGGCCTGCAGAG•CGAATTGAG•AGGAGCAGAAGTTCACGGTcATC•GGAACGGGCAGCTCCTCCAGGTCCCCGTG 750 
h A I L L S V I C V V L V T A F N D W S K E K Q F R G L Q S R [ E Q E Q K F T V I R N G Q L L Q V P V 208 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
GCTGcGCTGGTGGTGGGGGAcATTGCCcAGGTCAAGTAC~CGACCTGcTGCCAGCCGACGGcGTGCTCATCcAGGCCAATGACCTCAAGATCGACGAGAGCTCcCTGACGGGCGAGTCTGAcCACGTGCGCAAGTCAGCTGACAAAGAT 900 
GTCCTTCAGGGGAAGCTCACAAAGCTAGC CGTGCAGATCGGGAAAG•AGGGCTGGTGATGTCTGCCATCACCGTCAT•AT•CTG•TCCTCTACTTTGTGATTGAGACGTTTGTCGTGGAAGGCCGGACATGGCTGGCAGAGTGCACGCCG 1350 
h V L Q G K L T K L A V Q I G K A G L V M S A I T V I I L V L Y F V I E T F V V E G R T W L A E C T P 408 







h P D W D N E N E V V G D L T C I A V V G I E D P V R P E V P E A I R K C Q R A G I T V R M V T G D N 708 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
cT~A~T~cTG~cc~GTcG~cT~ccAcc~AcAAGcAc~AcT~GrcAAAGGGATTATc~Ac~GcAccA¢~GGT~A~cAGc~AGGTc~T~T~TGA~G~GGAT~cAc~AA~Ta~cG~cc~c~G~G~Ac~TG~Gc 2550 
h L R V L A R S S P T D K H T L V K G I I D S T T G E Q R Q V V A V T G D G T N D G P A L K K A D V G 808 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
TTCGCCATGGGCATCG•AGGGACCGACGTGGCCAAGGAGGC•TcCGACATCATCCTGACCGATGACAACTTCACCAGCATCGTCAAGGCAGTCATGTGGGGCCGTAACGTCTATGACAGCATCTCCAAGTTCCTGCAGTTTCAACTGAcG 2700 
h F A M G I A G T D V A K E A S D I I L T D D N F T S I V K A V M W G R N V Y D S I S K F L Q F Q L T 858 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
GTCAATGTGGTGGcTGTCATCGTGG••TTCACAGGTGCCTGCATTACTCAGGACTCTcCTCTcAAAGCcGTGCAGATGTTGTGGGTGAA•TTGATCATGGACAcATTTGC•T•TCTGG•CcTGGCGACGGAGCCACcCACAGAGTCGCTG 2850 
h V N V V A V I V A F T G A C I T Q D S P L K A V Q M L W V N L I M D T F A S L A L A T E P P T E S L 908 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
CTG•TGCGGAAGCCGTACGGCCGCGAcAAGCcCcTCATCTC•CGcACcATGATGAAGAAcATCCTGGGCCACG••GTGTAC•AGCTCGccATcAT•TTCAcCCTGCTGTTTGTCGGGGAG•T•TTCTTCGACATCGAcAGCGGGAGGAAT 3000 
h L L R K P Y G ~ D K P L I S R T M M K N I L G H A V Y Q L A I I F T L L F V G E L F F D I D S G ~ N 958 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . .  T . . . . . . . . . . . . . . . . . . . .  
G•GC•CCTGCACTCGCCACCCTCAGAGCA•TACAC•ATcAT•TTCAAcAcGTTCGTCATGATGCAGCTCTTTAACGAGAT•AACGCC•GCAAGATCcAcGGCGAGAGGAACGTGTTCGAcGGCAT•TTCAGCAA••CCATCTTCTG•Ac• 3150 
h A P L H S P P S E H Y T I I F N T F V M M Q L F N E I N A R K I H G E R N V F D G I F S N P I F C T 1008 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
ATCGTTTTGGGCACTTTCGGGATT•AGATTGTcATCGTC•AGTTTGGCGGGAAG•CCTTCAGCTGCTCcCcACTGTC•A•AGAACAGTGGcTCTGGTGCCTGTTTGTTGGTGTTGGGGAG•TGGT•TGGGGACAGGT•ATTG•CACCATC 3300 
h I V L G T F G I Q I V I V Q F G G K P F S C S P L S T E Q W L W C L F V G V G E L V W G Q v I A T I 1058 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
CCcACcAGcCAGCTCAAGTGcCTGAAGGAAGccGGGCAcGGGccCGGGAAGGACGAGATGACcGACGAGGAGCTGGcCGAAGGcGAGGAAGAGATcGACCATGcCGAGcGGGAGCTCCGCAGGGGCcAGATcCTCTGGTTCcGGGGCCTG 3450 
h P T S Q L K C L K E A G H G P G K D E M T D E E L A E G E E E I D H A E R E L R R G Q I L W F R G L 1108 
r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
h ( a ) r  h  b) ~CIGG~TT_~QG~ C ~6500 
r(b) . . . . . .  1114 
h(a)h(b}r (a) !~GiGVT!~T!K~S~C!~TC-P~G**TAGC~CGC;?T~AA~GCCTG~AGKAAA~CA~AA~CCKAAGTACC~CC~TTC;N~C~;~G~;~G~T~;~?C~ ~ 117337501157 
r(b) . . . . . . . . . . . . . . . . . . . . .  S C . . . . . . . . . . . . . . . . . .  
GCTCATTGACGACAC GGACGTG~ACGAGAACGAGGAGCGCCTCCGGGCCCCCCCGCCCCCGTCCCCCAACCAGAACAACAACGCCATAGACAGCGGCATCTACCTGACCACGCATGTCACCAAGTCAGCTACCTCTTCAGTGTTTTCCTC 3900 
h(b) L I D D T D V D E N E E R L R A P P P P S P N Q N N N A I D S G I Y L T T H V T K S A T S S V F S S 1207 
r{b) . . . . . . . . . . . . . . . . . . .  P . . . . . . . . . . . . . . .  A . . . . .  A - - - 
h(b) 
r(b) R . . . . . . .  M . . . .  * 
AGGGAACAACTAAGGTGGCTGAAGACCTTTCTGGCAGGGCATTTGCAAGGACCCAAATCCATT~AAC~AGGGTGCAGCCTGCCACAGGCTC~TCATCCGGACTGAGGAAGACGAGGACAGGGAGGAGGA~GGAGGAAGAGGAGGACAA 4200 
AAAGGGGGAGGAGAAGGTTCTTCGTCCA~GGAG 2234 
Fig. 2. Nucleotide sequence of the human PMCA3 cDNA and comparison of the deduced amino-acid sequence with that of the rat PMCA3 [5,11]. 
Nucleotide and deduced amino-acid sequences are numbered on the right, amino acids are shown in single-letter code. The human PMCA3 sequence (h) 
has been aligned with that of the rat (r). Sequence identity in the rat is indicated by a hyphen, translational stop codons are denoted by asterisks. 
Alternatively spliced sequences at sites A and C are shaded, the C-terminal amino-acid sequences of the (a) and (b) splice variants are shown separately. 
The positions of known intron interruptions in the 5'-end region of the human PMCA3 gene are indicated by black triangles above the nucleotide sequence. 
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fragment (positions 130 to 680 in [5]), generated by re- 
verse transcriptase PCR (RT-PCR) on rat brain RNA was 
used initially as probe to screen a human Alzheimer's 
disease brain cDNA library (Clontech HL1028b). This 
resulted in the isolation of a 0.7 kb clone (hAlz4.1) 
specifying a region close to the N-terminus of the human 
PMCA3 (nucleotides 241 to 955 in Fig. 2). The insert of 
this clone was then used to screen a human hippocampus 
cDNA library (Clontech HL1088a) as well as a human 
leukocyte genomic DNA library (Clontech HLI006d). In 
addition, the hippocampus cDNA library was also screened 
with a RT-PCR-derived fragment covering the C-termi- 
nally located splice-site C region [10]. The genomic 
screening yielded a clone (AHII5.2) containing at least 6 
exons of the human PMCA3 gene, including the first 
coding exon which specifies 126 nucleotides of the 5' 
untranslated region and the N-terminal 69 amino acid 
codons (Fig. 1). The cDNA screenings resulted in the 
isolation of clones hBr27.1 and hBrl. 1. carrying inserts of 
about 1.5 and 1.6 kb, respectively. The insert of hBr27.1 
extended the PMCA3 sequence to position 1857 and that 
of hBrl. 1 provided the 3'-end sequence from position 2549 
to 4170. The remaining sequence gap was filled by RT-PCR 
according to published procedures [15] on RNA from 
human IMR-32 neuroblastoma cells and using primers 
derived from the previously determined human or rat [5] 
PMCA3 sequences. A schematic map of the human 
PMCA3 cDNA and its coverage by the different overlap- 
ping clones is shown in Fig. 1. The complete cDNA 
sequence of hPMCA3 is displayed in Fig. 2 and its pre- 
dicted amino-acid sequence is compared with that of the 
rat PMCA3 isoform. 
Comparison of the human and rat PMCA3 isoforms. 
The comparison i  Fig. 2 of both the 3a and the 3b splice 
variants of PMCA3 (also termed 3CII and 3CI, respec- 
tively, in a recently proposed new nomenclature [3]) illus- 
trates the high degree of sequence similarity between the 
human and rat isoforms (about 98% identity and 99% 
similarity). These numbers are comparable to the identities 
between the corresponding PMCA1 and PMCA2 isoforms 
[6]. By contrast, the rat and human PMCA4 are less well 
conserved, showing only 87% identity [6]. With the com- 
pletion of the human PMCA3 cDNA sequence, the entire 
set of all four rat and human PMCA isoforms has now 
been characterized at the amino-acid sequence l vel. At the 
nucleotide level, pairwise comparisons between the human 
and rat [5] PMCA3 sequences reveal 89% identity in the 
coding region, a remarkably high 77% identity in the 
available 126 nucleotides of 5' untranslated sequence, and 
66% identity in the first 250 nucleotides of the 3' untrans- 
lated region. The gene structure of the rat PMCA3 has 
previously been elucidated [11]. The 6 exons of the human 
PMCA3 gene identified in clone AH115.2 correspond pre- 
cisely to exons 3 to 8 of the rat gene: intron interruptions 
occur at identical positions in the two genes (Fig. 2 and 
[11]). 
J 
7.5 kb - -  
4.4 kb -- 
Fig. 3. Analysis of hPMCA3 mRNA expression in human tissues. A 
poly(A) + RNA multiple human tissue Northern blot (Clontech) was 
hybridized with a 32 P-labeled hPMCA3-specific probe derived from the 
5' end of the cDNA. The washed blot was exposed for 72 h to a 
Phosphorlmager (Molecular Dynamics) screen. The positions of 7.5 kb 
and 4.4 kb molecular size standards are indicated on the left, and the 
tissue source of the RNA is indicated on top of each lane. 
Expression of human PMCA3 mRNA. To further con- 
firm the identity of the cloned PMCA cDNA and to obtain 
information on the size of its nature mRNA, a multiple 
human tissue Northern blot (Clontech) was hybridized 
with a radiolabeled probe [16] corresponding topositions 1 
to 171 of the hPMCA3 sequence (Fig. 2). The probe 
fragment was generated by PCR on clone AH115.2 and 
corresponded to the available 5' untranslated region and 
the 15 amino terminal codons. A single, major band 
corresponding to a mRNA of about 7 kb was detected by 
this probe on the Northern blot (Fig. 3). Of all tissues 
tested, only brain expressed significant amounts of 
PMCA3; no signal was detected in heart and skeletal 
muscle, placenta, lung, liver, kidney and pancreas (Fig. 3). 
These data are in agreement with previous findings using 
RT-PCR [10,15] and Western blotting techniques [13] 
demonstrating that in humans, PMCA3 expression is es- 
sentially restricted to neuronal tissues in the brain as well 
as to fetal skeletal muscles. By contrast, the rat PMCA3 is 
also abundantly expressed in adult skeletal muscle, and an 
alternatively spliced 4.5 kb mRNA is readily detected in 
addition to the 7.5 kb mRNA in this tissue [5,11]. Thus, 
despite their very high degree of similarity at the coding 
and, presumably, the genomic level the expression patterns 
of the rat and human PMCA3 isoforms do not entirely 
coincide. It will be of interest o unravel the mechanisms 
of the highly neuron-specific expression of the human 
PMCA3 and the significance of this isoform for Ca 2+ 
handling in the brain. 
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